Exact Mass: 491.26479020000005
Exact Mass Matches: 491.26479020000005
Found 130 metabolites which its exact mass value is equals to given mass value 491.26479020000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
DB-065692
C27H41NO5S (491.2705296000001)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents
Epothilone D
C27H41NO5S (491.2705296000001)
Ala His His Lys
C21H33N9O5 (491.26045280000005)
Ala His Lys His
C21H33N9O5 (491.26045280000005)
Ala Lys His His
C21H33N9O5 (491.26045280000005)
Phe Ile Asn Val
Phe Ile Val Asn
Phe Lys Pro Thr
Phe Lys Thr Pro
Phe Leu Asn Val
Phe Leu Val Asn
Phe Asn Ile Val
Phe Asn Leu Val
Phe Asn Val Ile
Phe Asn Val Leu
Phe Pro Lys Thr
Phe Pro Thr Lys
Phe Gln Val Val
Phe Thr Lys Pro
Phe Thr Pro Lys
Phe Val Ile Asn
Phe Val Leu Asn
Phe Val Asn Ile
Phe Val Asn Leu
Phe Val Gln Val
Phe Val Val Gln
His Ala His Lys
C21H33N9O5 (491.26045280000005)
His Ala Lys His
C21H33N9O5 (491.26045280000005)
His His Ala Lys
C21H33N9O5 (491.26045280000005)
His His Lys Ala
C21H33N9O5 (491.26045280000005)
His Lys Ala His
C21H33N9O5 (491.26045280000005)
His Lys His Ala
C21H33N9O5 (491.26045280000005)
Ile Phe Asn Val
Ile Phe Val Asn
Ile Asn Phe Val
Ile Asn Val Phe
Ile Val Phe Asn
Ile Val Asn Phe
Lys Ala His His
C21H33N9O5 (491.26045280000005)
Lys Phe Pro Thr
Lys Phe Thr Pro
Lys His Ala His
C21H33N9O5 (491.26045280000005)
Lys His His Ala
C21H33N9O5 (491.26045280000005)
Lys Pro Phe Thr
Lys Pro Thr Phe
Lys Thr Phe Pro
Lys Thr Pro Phe
Leu Phe Asn Val
Leu Phe Val Asn
Leu Asn Phe Val
Leu Asn Val Phe
Leu Val Phe Asn
Leu Val Asn Phe
Asn Phe Ile Val
Asn Phe Leu Val
Asn Phe Val Ile
Asn Phe Val Leu
Asn Ile Phe Val
Asn Ile Val Phe
Asn Leu Phe Val
Asn Leu Val Phe
Asn Val Phe Ile
Asn Val Phe Leu
Asn Val Ile Phe
Asn Val Leu Phe
Pro Phe Lys Thr
Pro Phe Thr Lys
Pro Lys Phe Thr
Pro Lys Thr Phe
Pro Thr Phe Lys
Pro Thr Lys Phe
Gln Phe Val Val
Gln Val Phe Val
Gln Val Val Phe
Thr Phe Lys Pro
Thr Phe Pro Lys
Thr Lys Phe Pro
Thr Lys Pro Phe
Thr Pro Phe Lys
Thr Pro Lys Phe
Val Phe Ile Asn
Val Phe Leu Asn
Val Phe Asn Ile
Val Phe Asn Leu
Val Phe Gln Val
Val Phe Val Gln
Val Ile Phe Asn
Val Ile Asn Phe
Val Leu Phe Asn
Val Leu Asn Phe
Val Asn Phe Ile
Val Asn Phe Leu
Val Asn Ile Phe
Val Asn Leu Phe
Val Gln Phe Val
Val Gln Val Phe
Val Val Phe Gln
Val Val Gln Phe
(1R,2S,4R,5R,8R,9S,11S)-2-[[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyloxan-2-yl]oxymethyl]-9-formyl-5-methyl-13-propan-2-yltetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylate
C27H39O8- (491.26447939999997)
(13E)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
C27H41NO5S (491.2705296000001)
cyclopropyl-[(1R)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
C29H34FN3O3 (491.25840660000006)
[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-fluorophenyl)methanone
C29H34FN3O3 (491.25840660000006)
[(1S)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-fluorophenyl)methanone
C29H34FN3O3 (491.25840660000006)
cyclopropyl-[(1S)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
C29H34FN3O3 (491.25840660000006)
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
C23H42NO8P (491.26479020000005)
2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(dimethylamino)ethyl]-4-quinolinecarboxamide
C24H41N3O4Si2 (491.26354660000004)
Epothilone D
C27H41NO5S (491.2705296000001)
An epithilone that is epithilone C in which the hydrogen at position 13 of the oxacyclohexadec-13-ene-2,6-dione macrocycle has been replaced by a methyl group. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents
phosphatidylethanolamine 18:2 zwitterion
C23H42NO8P (491.26479020000005)
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 18 carbons and 2 double bonds.
PE(18:2)
C23H42NO8P (491.26479020000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(15:2)
C23H42NO8P (491.26479020000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2s,5s,10r,13r,14r,17s,18s)-4-ethyl-13,14-dihydroxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosan-18-yl (2z)-3-phenylprop-2-enoate
C30H37NO5 (491.26715920000004)
17-benzyl-19-hydroxy-5,7,14,15-tetramethyl-6-oxo-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-yl acetate
C30H37NO5 (491.26715920000004)
(1r,2r,3z,5s,7s,9z,11r,12s,14r,15s,16r,17s)-17-benzyl-19-hydroxy-5,7,14,15-tetramethyl-6-oxo-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-yl acetate
C30H37NO5 (491.26715920000004)